Lv1
24 积分 2024-09-24 加入
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy
3个月前
已完结
An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
10个月前
已完结
Methods and applications of in vivo CRISPR screening
10个月前
已完结
In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy
10个月前
已完结
Am I ready for CRISPR? A user's guide to genetic screens
1年前
已完结
Engineered CAR-NK Cells for Cancer Immunotherapy: Lentiviral-Based CAR Transduction of NK-92 Cells
1年前
已完结
Prime editor-based high-throughput screening reveals functional synonymous mutations in human cells
1年前
已完结